Online Media Kit

FEATURED STORY

March 16, 2022 | Times LIVE (South Africa)

More HIV prevention options for SA women as vaginal ring approved

The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women. More »

FEATURED STORY

February 26, 2022 | The East African (Kenya)

Young women prefer vaginal ring to daily oral pill for HIV prevention

Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring. More »

FEATURED STORY

January 26, 2021 | World Health Organization

WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection

WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »

Media Highlights

December 31, 2018 | Specialty Medical Dialogues (India)

Dapivirine use for HIV prevention safe in periconception period

The study, published in the Journal of Acquired Immune Deficiency Syndromes, shows that dapivirine use in the periconception period does not seem to be associated with adverse effects on pregnancy or... More »

November 29, 2018 | Johnson & Johnson News

"I Have HIV": This Researcher Is Fighting the Disease—and the Stigma Attached to It

Johnson & Johnson profiles IPM Scientific Advisory Board member Jens Van Roey. More »

November 01, 2018 | The Body PRO

Dapivirine Vaginal Ring for PrEP Does Not Lead to Drug Resistance

MTN research presented at R4P 2018 found that use of the dapivirine vaginal ring did not lead to resistance mutations in women participating in ASPIRE who seroconverted.  More »

October 31, 2018 | Aidsmap

Going local – prevention conference hears about rings, douches, and soluble suppositories

There is still interest in topical (local) alternatives to systemic (oral or injected) PrEP that will not cause viral resistance, may be relatively easy to develop in the short term, may be preferred... More »

October 27, 2018 | Citizen News Service (CNS)

We want the ring..

That seemed to be the resonating refrain of women at the HIV Research for Prevention Conference (HIVR4P2018) held recently in Madrid, Spain. And no, they were not talking about the engagement ring.  More »

Pages